Rhodemann Li

RhodemannLi-Vesselon

Vesselon

2018

Affiliations

Columbia University

Technologies

Therapeutic

Indication

Immunotherapy

Neurology

Oncology

Executive Summary

View/Download

Vesselon is commercializing a drug delivery platform that significantly increases the biodistribution of small molecules, large antibodies, or viral vectors directly to the target tissue by repurposing an FDA-approved microbubble (Imagent(R)) for drug delivery, without having to change the therapeutic agent in any way.

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An intiative of